A 24 Week Efficacy Study of Inhaled Umeclidinium (UMEC) in Patients of Chronic Obstructive Pulmonary Disease (COPD) Using a Novel Dry Powder Inhaler (NDPI)
Clinical trial NCT02184611 · COMPLETED
Trial details
- NCT number
- NCT02184611
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-09
- Primary completion
- 2017-11-08
- Enrollment
- 308
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.